The Role of Vitamin D Supplementation on Well Being & Symptoms of

Status Completed

Clinical Trial Summary

The purpose of this study is to investigate whether vitamin D3 (70 micrograms) is better than placebo in preventing depression symptoms among employees in health care

Clinical Trial Description

Vitamin D3 is produced in the skin after exposure to ultraviolet B light from the sun. Vitamin D3 is metabolised sequential in the liver into 25-hydroxy-vitamin D [25(OH)D], which is the storage form of vitamin D in the body, and then in the kidney into the steroid hormone, 1a,25-dihydroxyvitamin 1a,25-dihydroxyvitamin D [1,25(OH)2D].

At higher latitudes ultraviolet B light is stopped by the atmosphere during winter season. Half of Danes have low levels of [25(OH)D] in the blood and especially in the early spring months the levels of [25(OH)D] are low. In addition, Vitamin D3 is absorbed through the gut from vitamin D-rich food sources. But several studies show that it is not possible through a recommended diet, which consists of 300 g of fish per week to consume adequate amounts of vitamin D3.

New research suggests link between vitamin D3 and brain function.In the Central Nervous System (CNS) there are specific nuclear receptors for 1,25(OH)2D (VDR) and the enzymes necessary for the hydroxylation of 25(OH)D to 1,25(OH)2D are also present in CNS.

In clinical studies, low serum levels of 25(OH)D, have been associated with reduced cognitive function, anxiety and depression.

The objective of this randomized clinical trial is to investigate whether indoor employees, with tendency to depressive symptoms in the winter season, should be offered vitamin D3 supplements during the Winter season, or it has no significance in relation prevent depressive symptoms.

The study is carried out in the winter season in the Region of Southern Denmark for 12 weeks and offered to health service staff, who have a tendency for depressive symptoms in the winter season. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01462058
Study type	Interventional
Source	Region Syddanmark
Contact
Status	Completed
Phase	Phase 4
Start date	October 2011
Completion date	March 2012

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT06267534` - Mindfulness-based Mobile Applications Program	N/A
Completed	`NCT04108689` - Internet-based Acceptance and Commitment Training for Elite Ice Hockey Players	N/A
Recruiting	`NCT06012084` - The Development and Evaluation of iCF-PWR for Healthy Siblings of Individuals With Cystic Fibrosis	N/A
Completed	`NCT04085861` - Mental Health in Dancers; an Intervention Study	N/A
Recruiting	`NCT05227352` - Bio-Experiential Spaces for Mental Health in Healthworkers	N/A
Completed	`NCT03663075` - Effect of Group Education and Individual Counselling on Mental Health and Quality of Life in 45-60 Year Old Women	N/A
Completed	`NCT02480907` - Supporting Carers of Children and Adolescents With Eating Disorders in Austria (SUCCEAT)	N/A
Completed	`NCT02157766` - Wisconsin Center for the Neuroscience and Psychophysiology of Meditation	N/A
Completed	`NCT01155687` - Psychosocial Counseling in Afghanistan	N/A
Unknown status	`NCT01177696` - Intervention in Groups of Family Caregivers in Primary Health Care	N/A
Completed	`NCT01037946` - Family to Family: Psychoeducation to Improve Children's Outcomes in HIV+ Families	N/A
Completed	`NCT00700349` - Evaluation of Impacts of Access to Credit and Loan Size for Microcredit Clients in South Africa	N/A
Recruiting	`NCT03885401` - Enhanced Care Planning for Patients With Multiple Chronic Conditions	N/A
Completed	`NCT03118388` - Engaging Homeless Youth in Vocational Training to Meet Their Mental Health Needs	Phase 2
Completed	`NCT05061966` - The Digital Wellbeing Project	N/A
Completed	`NCT04026308` - Written vs Electronic Safety Planning Study	N/A
Completed	`NCT04546061` - Project Uplift: Substance Use and Mental Health Treatment for Young Sexual and Gender Minorities	N/A
Completed	`NCT05738109` - Evaluating the Efficacy of a 91-day Self-talk Mental Health Self-care Journal	N/A
Completed	`NCT03901274` - Partnering for Student Wellness	N/A
Not yet recruiting	`NCT05910580` - Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

The Role of Vitamin D Supplementation on Well Being and Symptoms of Depression During the Winter Season in Health Service Staff — D3-vit-SAD

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms